These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 205843)

  • 1. [Treatment of type II hyperlipoproteinemia--personal experiences].
    Sznajderman M
    Pol Arch Med Wewn; 1978 Feb; 59(2):153-60. PubMed ID: 205843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of type IV and V hyperlipemia--personal experiences].
    Sznajderman M
    Pol Arch Med Wewn; 1978 Feb; 59(2):161-9. PubMed ID: 205844
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lowering of the lipoproteins in type IIa hyperlipoproteinemia by means of bezafibrate. Comparison with clofibrate].
    Mertz DP; Suermann I; Loewer H
    MMW Munch Med Wochenschr; 1979 Oct; 121(40):1295-6. PubMed ID: 226879
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypolipidemic activity of trimethylglycine].
    Kliueva NN; Kalashnikova NM; Okunevich IV; Sapronov NS
    Eksp Klin Farmakol; 2012; 75(1):16-8. PubMed ID: 22442957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
    G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
    Saito Y; Shinomiya M; Shirai K; Yoshida S
    Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
    [No Abstract]   [Full Text] [Related]  

  • 10. [Classification and metabolic patterns of hyperlipoproteinemia, with special reference to serum lipoprotein metabolism].
    Kimura N; Nanbu S
    Nihon Rinsho; 1975 Nov; 33(11):3147-56. PubMed ID: 173902
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification and management of familial hyperlipoproteinemia.
    Wessler S; Avioli LA
    JAMA; 1969 Feb; 207(5):929-33. PubMed ID: 5818258
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipoproteinemias in the prematurely aged. Theories of pathogenesis, diagnosis, classification, and treatment.
    Herrmann GR
    Geriatrics; 1970 Apr; 25(4):103-14. PubMed ID: 5443794
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of hyperlipoproteinemia to colestipol.
    Sachs BA; Wolfman L
    N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
    [No Abstract]   [Full Text] [Related]  

  • 14. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 15. Atherosclerosis as a pediatric problem.
    Wells CR
    Del Med J; 1974 Sep; 46(9):457-63. PubMed ID: 4369794
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic retinopathy and serum lipids.
    Su DH; Yeo KT
    Singapore Med J; 2000 Jun; 41(6):295-7. PubMed ID: 11109348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic principles of drug therapy of hyperlipoproteinemia].
    Romics L
    Orv Hetil; 1988 Nov; 129(45):2391-9. PubMed ID: 3054710
    [No Abstract]   [Full Text] [Related]  

  • 18. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of serum cholesterol in type II hyperlipidaemia by guar gum.
    Jenkins DJ; Leeds AR; Slavin B; Mann J; Jepson EM
    Proc Nutr Soc; 1977 Dec; 36(3):94A. PubMed ID: 202966
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical aspects of hyperlipoproteinemia.
    Crepaldi G; Fellin R
    Ann Biol Clin (Paris); 1974; 32(4):309-22. PubMed ID: 4376343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.